
Plus Therapeutics Reports First Quarter Financial Results And Recent Business Highlights
(MENAFN- GlobeNewsWire - Nasdaq) Company continues to progress both REYOBIQTM radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the“ …